Tympanomastoidectomy. Chronic tubotympanic suppurative otitis media,Chronic atticoantral suppurative otitis media,Other chronic suppurative otitis media,Suppurative otitis media, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients underwent canal wall down tympanomastoidectomy and discharge within 8 hours after surgery (day-case discharge). Intervention 2: Control group: Patients und
Treatment - Surgery
Intervention group: Patients underwent canal wall down tympanomastoidectomy and discharge within 8 hours after surgery (day-case discharge).
Control group: Patients underwent canal wall down tympanomastoidectomy and discharge routinely, 24 hours after surgery.
Sponsors
Vice Chancellor for Research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients more than 18 years old who have indication of canal wall down tympanomastoidectomy; availability to telephone or cell phone; patients dwell inside shiraz; availability of personal car; care of patients by their family at home; sign of consent form; low anesthesia risk (score=1); having discharge criteria included: the patients who are awake and alert with stable vital signs, cases who are mobile, could tolerate fluids; educated patients or their family (high school or more than high school); tympanic perforation= 50%. Exclusion criteria: pre operative medical problems such as asthma, diabetes, coagulation disorders, cardiovascular disease, basic metabolic disorder, immune system deficiency and chronic liver or renal disease; do not have someone for care of patients at home; patients dwell outside shiraz; intraoperative complications such as iathrogenic facial nerve truma, iathrogenic displacement of stapes, labirynthin fistula, dural tearing and CSF leakage; Patient with recurrent emesis, vertigo and uncontrolled pain, not relieved by acetaminophen; revision surgery; Smoker patients; Patients with preoperative mixed hearing loss; Patients with contra-lateral ear disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting (PONV). Timepoint: every 4 hours for 24 hours postoperatively. Method of measurement: Observation by trained nurse staff in overnight admission group - selfreport by payients in day-case group.;Postoperative pain. Timepoint: within 24 hours postoperatively ( 2, 4, 8, 16 & 24 Hours after operation). Method of measurement: Visual Analog Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Tympanic membrane graft success rate. Timepoint: 6 months after operation. Method of measurement: Observation by surgeon.;Hearing threshold. Timepoint: before operation - 6 months after operation. Method of measurement: pure tone audiometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSareh Roosta
Center for Development of Clinical Studies- Vice Chancellery of Research and Technology- Shiraz Univ
Outcome results
None listed